FDA approves much-debated Alzheimer’s drug Biogen, 1st in nearly 20 years
The Food and Drug Administration said it granted approval to the drug developed by Biogen for patients with Alzheimer's disease.
The Food and Drug Administration said it granted approval to the drug developed by Biogen for patients with Alzheimer's disease.